Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last A$0.06 AUD
Change Today +0.001 / 1.67%
Volume 681.8K
As of 10:37 PM 04/26/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Susan L. Kelley M.D.

Non-Executive Director, Chairman of Science & Technology Committee, Member of Remuneration Committee and Member of Nomination Committee, Alchemia Limited
AgeTotal Calculated CompensationThis person is connected to 41 board members in 4 different organizations across 4 different industries.

See Board Relationships


Dr. Susan L. Kelley, M.D, served as the Chief Medical Officer of Multiple Myeloma Research Consortium and The Multiple Myeloma Research Foundation/Consortium from July 2008 to March 2011. Dr. Kelley is a successful oncology drug developer and has a rare breadth and depth of drug development experience. Dr. Kelley developed drugs in oncology and immunology for over 25 years. She held positions of increasing responsibility at Bristol-Myers Squibb in Oncology and Immunology ...

Read Full Background

Corporate Headquarters*

3 Hi –Tech Court Brisbane Technology Park
Brisbane, Queensland 4113


Phone: 61 7 3340 0200
Fax: 61 7 3340 0222

Board Members Memberships*

Director and Member of Science Committee
Non-Executive Director, Chairman of Science & Technology Committee, Member of Remuneration Committee and Member of Nomination Committee
Director and Chairman of Clinical Advisory Committee


Colgate University
Duke University Medical Center

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Unexercisable Options ValueA$191,000
Total Value of OptionsA$191,000

Total Compensation*

Total Annual Cash CompensationA$60,000
Total Calculated CompensationA$87,728
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACL:AU A$0.06 AUD +0.001


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALCHEMIA LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at